Section 11167.5 Of Article 1. Requirements Of Prescriptions From California Health And Safety Code >> Division 10. >> Chapter 4. >> Article 1.
11167.5
. (a) An order for a controlled substance classified in
Schedule II for a patient of a licensed skilled nursing facility, a
licensed intermediate care facility, a licensed home health agency,
or a licensed hospice may be dispensed upon an oral or electronically
transmitted prescription. If the prescription is transmitted orally,
the pharmacist shall, prior to filling the prescription, reduce the
prescription to writing in ink in the handwriting of the pharmacist
on a form developed by the pharmacy for this purpose. If the
prescription is transmitted electronically, the pharmacist shall,
prior to filling the prescription, produce, sign, and date a hard
copy prescription. The prescriptions shall contain the date the
prescription was orally or electronically transmitted by the
prescriber, the name of the person for whom the prescription was
authorized, the name and address of the licensed skilled nursing
facility, licensed intermediate care facility, licensed home health
agency, or licensed hospice in which that person is a patient, the
name and quantity of the controlled substance prescribed, the
directions for use, and the name, address, category of professional
licensure, license number, and federal controlled substance
registration number of the prescriber. The original shall be properly
endorsed by the pharmacist with the pharmacy's state license number,
the name and address of the pharmacy, and the signature of the
person who received the controlled substances for the licensed
skilled nursing facility, licensed intermediate care facility,
licensed home health agency, or licensed hospice. A licensed skilled
nursing facility, a licensed intermediate care facility, a licensed
home health agency, or a licensed hospice shall forward to the
dispensing pharmacist a copy of any signed telephone orders, chart
orders, or related documentation substantiating each oral or
electronically transmitted prescription transaction under this
section.
(b) This section shall become operative on July 1, 2004.